Lee Perry, MD
Allergy & Immunology · Chattanooga, TNNPI 1225252125
Payments from drug & device makers
Across 522 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$1K
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$1K
- AstraZeneca$1K
- Pfizer$691
- Takeda Pharmaceuticals U.S.A., Inc.$592
- plus $4K from 32 others
What the payments were for
- Speaking & faculty fees$2002%
- Food & beverage$9,62597%
- Education$1081%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 67 | $1,382 |
| GSK | 99 | $1,171 |
| Regeneron Healthcare Solutions, Inc. | 46 | $1,121 |
| AstraZeneca | 49 | $1,020 |
| Pfizer | 40 | $691 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $592 |
| Sanofi | 31 | $584 |
| Grifols USA, LLC | 18 | $376 |
| Genentech USA, Inc. | 20 | $352 |
| Octapharma USA, Inc. | 3 | $321 |
| Shire North American Group Inc | 4 | $244 |
| Amgen | 11 | $235 |
| Optinose US, Inc. | 11 | $211 |
| Pharming Healthcare, Inc. | 11 | $205 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $201 |
| Covis Pharma GmbH | 10 | $177 |
| Novartis | 9 | $149 |
| Biocryst US Sales Co., LLC | 7 | $126 |
| Sanofi-aventis U.S. LLC | 1 | $95 |
| Sunovion Pharmaceuticals Inc. | 6 | $94 |
| AbbVie | 5 | $85 |
| Kaleo, Inc. | 4 | $63 |
| Johnson & Johnson | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Bio Products Laboratory USA, Inc. | 2 | $38 |
| Cycle Pharmaceuticals Inc | 2 | $37 |
| Merck | 2 | $35 |
| Boehringer Ingelheim | 2 | $34 |
| Hikma Pharmaceuticals USA | 2 | $27 |
| Greer Laboratories, Inc. | 1 | $25 |
| Johnson & Johnson Vision Care, Inc. | 1 | $22 |
| Incyte Corporation | 1 | $18 |
| GC Biopharma USA, Inc. | 1 | $18 |
| Alk-abello, Inc | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| LEO Pharma Inc. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CUTAQUIG$223
How this compares
$9,933 in reported general payments places this provider in the 70th percentile of 79 allergy & immunology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 167 | $146,985 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 11 | $69,774 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 13 | $69,227 |
| XolairOmalizumab | 22 | $66,443 |
| Dupixent PenDupilumab | 16 | $61,303 |
| TezspireTezepelumab-Ekko | 13 | $56,519 |
| Breo ElliptaFluticasone/Vilanterol | 84 | $38,054 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 40 | $26,054 |
| Spiriva RespimatTiotropium Bromide | 28 | $17,028 |
| SymbicortBudesonide/Formoterol Fumarate | 68 | $16,971 |
| Azelastine Hcl | 333 | $10,261 |
| Epinephrine | 55 | $9,941 |
| Arnuity ElliptaFluticasone Furoate | 38 | $8,473 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 39 | $7,119 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 286 | $6,508 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $1,171 | $193,512289 claims |
| AstraZenecaTezspire, Breztri Aerosphere, Symbicort | $1,020 | $99,544121 claims |
| CSL BehringHizentra | $1,382 | $69,77411 claims |
| Grifols USA, LLCGamunex-C | $376 | $69,22713 claims |
| Boehringer IngelheimSpiriva Respimat | $34 | $17,02828 claims |
| Hikma Pharmaceuticals USAEpinephrine | $27 | $9,94155 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 79 allergy & immunology providers in Tennessee.
Other allergy & immunology in Chattanooga
- Marc CromieChattanooga$106K
- Todd LevinChattanooga$64K
- Susan RaschalChattanooga$40K
- Jennifer PatelChattanooga$12K
- Joseph WisniewskiChattanooga$6K
- David ChaffinChattanooga$5K
- Jessica van MasonChattanooga$5K
- Taylor AtchleyChattanooga$4K
- Michael HollieChattanooga$3K
- Paul CarterChattanooga$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.